1Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria lbr definite antiphospholipid syndrome (APS). J Thromb Haemost 2006:4: 295-306.
2Mitic G, Novakov MA, Povazan L, Mitreski A, Kopitovic V, Vejnovic T. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia. Med Pregl 2011; 64:471-475.
3Gibson PS, Powrie R. Anticoagulants and pregnancy: when are they safe? Cleve Clin J Med 2009; 76:113-127.
4Pass SE, Simpson RW. Discontinuation and reinstitution of medications during the perioperative period. Am J Health Syst Pharm 2004; 61: 899-912.
5Vucic N, Frleta M, Petrovic D, Ostojic V. Thrombophilia, preeclampsia and other pregnancy complications. Acta Med Croatica 2009; 63: 297-305.
6谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
7Lyall F,Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction :relationship to clinical outcome [ J]. Hypertension, 2013,62 (6) : 1046 - 1054.
8Cohen J, Guedj J, Fries N. Umbilical artery Doppler assessment :a clear disparity in ultrasound practice in a national survey [J]. Acta Obstet Gynecol Scand, 2013,92 ( 9 ): 1115-1116.
9Unterscheider J, Daly S, 0Donoghue K, Critical umbilical artery Doppler abnormalities in early fetal growth restriction and the timing of delivery: an overestimated clinical challenge in daily obstetric practice?[J],Ultrasound Obstet Gynecol, 2014,43 (2) : 236 -237.
10Mura c evi c B,Hod2i c J,Badir J. Effect of antihypertensive therapy with alpha - methyldopa on umbilical artery Doppler in pregnancies with hypertensive disorders[ J]. Med Glas (Zen-ica),2013,10 (2) : 278 -282.
